hydralazine has been researched along with Cardiac Output, Low in 18 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
Cardiac Output, Low: A state of subnormal or depressed cardiac output at rest or during stress. It is a characteristic of CARDIOVASCULAR DISEASES, including congenital, valvular, rheumatic, hypertensive, coronary, and cardiomyopathic. The serious form of low cardiac output is characterized by marked reduction in STROKE VOLUME, and systemic vasoconstriction resulting in cold, pale, and sometimes cyanotic extremities.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The hemodynamic benefits of combined administration of prenalterol (P) with hydralazine (H) were evaluated in ten patients with severe chronic heart failure." | 7.66 | Short- and long-term effects of hydralazine and combined hydralazine-prenalterol therapy in severe chronic congestive heart failure. ( Drexler, H; Just, H; Löllgen, H, 1981) |
| "The hemodynamic benefits of combined administration of prenalterol (P) with hydralazine (H) were evaluated in ten patients with severe chronic heart failure." | 3.66 | Short- and long-term effects of hydralazine and combined hydralazine-prenalterol therapy in severe chronic congestive heart failure. ( Drexler, H; Just, H; Löllgen, H, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (38.89) | 18.7374 |
| 1990's | 6 (33.33) | 18.2507 |
| 2000's | 5 (27.78) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Klein, L | 1 |
| O'Connor, CM | 1 |
| Gattis, WA | 1 |
| Zampino, M | 1 |
| de Luca, L | 1 |
| Vitarelli, A | 1 |
| Fedele, F | 1 |
| Gheorghiade, M | 1 |
| Ferdinand, KC | 1 |
| McNamara, DM | 1 |
| Tam, SW | 2 |
| Sabolinski, ML | 2 |
| Tobelmann, P | 1 |
| Janosko, K | 1 |
| Taylor, AL | 2 |
| Cohn, JN | 3 |
| Feldman, AM | 1 |
| Worcel, M | 2 |
| Franciosa, JA | 1 |
| Lindenfeld, J | 1 |
| Ziesche, S | 1 |
| Walsh, MN | 1 |
| Mitchell, JE | 1 |
| Adams, K | 1 |
| Ofili, E | 1 |
| Novikov, SV | 1 |
| Mareev, VIu | 1 |
| Greenberg, BH | 1 |
| Rahimtoola, SH | 1 |
| Drexler, H | 1 |
| Löllgen, H | 1 |
| Just, H | 1 |
| Swartz, MT | 1 |
| Kaiser, GC | 1 |
| Willman, VL | 1 |
| Codd, JE | 1 |
| Tyras, DH | 1 |
| Barner, HB | 1 |
| Bates, ER | 1 |
| Crevey, BJ | 1 |
| Sprague, FR | 1 |
| Pitt, B | 1 |
| Hindman, MC | 1 |
| Slosky, DA | 1 |
| Peter, RH | 1 |
| Newman, GE | 1 |
| Jones, RH | 1 |
| Wallace, AG | 1 |
| Stevenson, WG | 1 |
| Stevenson, LW | 1 |
| Middlekauff, HR | 1 |
| Fonarow, GC | 1 |
| Hamilton, MA | 1 |
| Woo, MA | 1 |
| Saxon, LA | 1 |
| Natterson, PD | 1 |
| Steimle, A | 1 |
| Walden, JA | 1 |
| Tillisch, JH | 1 |
| Adams, KF | 1 |
| Ellis, ML | 1 |
| Williamson, KM | 1 |
| Patterson, JH | 1 |
| Verma, SP | 1 |
| Silke, B | 1 |
| Reynolds, GW | 1 |
| Kelly, JG | 1 |
| Richmond, A | 1 |
| Taylor, SH | 1 |
| Strauer, BE | 1 |
| Dékány, M | 1 |
| Bányai, F | 1 |
| Antalóczy, Z | 1 |
4 reviews available for hydralazine and Cardiac Output, Low
| Article | Year |
|---|---|
Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiac Output, Low; Cardioto | 2003 |
Isosorbide dinitrate and hydralazine hydrochloride: a review of efficacy and safety.
Topics: Black or African American; Cardiac Output, Low; Drug Combinations; Humans; Hydralazine; Isosorbide D | 2005 |
Fixed combination isosorbide dinitrate-hydralazine for nitric-oxide-enhancing therapy in heart failure.
Topics: Cardiac Output, Low; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Ni | 2006 |
[Adrenergic alpha-receptor blockaders and direct arteriolar vasodilators in treatment of chronic cardiac insufficiency].
Topics: Adrenergic alpha-Antagonists; Arterioles; Cardiac Output, Low; Chronic Disease; Hemodynamics; Humans | 1983 |
1 trial available for hydralazine and Cardiac Output, Low
| Article | Year |
|---|---|
Comparative study on the short-term effects of angiotensin converting enzyme inhibitors (Lopirin, SQUIBB and Tensiomin), and dihydralazine in chronic cardiac failure.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cardiac Output, Lo | 1988 |
13 other studies available for hydralazine and Cardiac Output, Low
| Article | Year |
|---|---|
Aldosterone synthase promoter polymorphism predicts outcome in African Americans with heart failure: results from the A-HeFT Trial.
Topics: Aged; Alleles; Black or African American; Cardiac Output, Low; Cohort Studies; Cytochrome P-450 CYP1 | 2006 |
Outcomes by gender in the African-American Heart Failure Trial.
Topics: Adult; Aged; Black or African American; Cardiac Output, Low; Drug Therapy, Combination; Female; Hosp | 2006 |
Vasodilator therapy for valvular heart disease.
Topics: Aortic Valve Insufficiency; Cardiac Output, Low; Heart Valve Diseases; Hemodynamics; Humans; Hydrala | 1981 |
Short- and long-term effects of hydralazine and combined hydralazine-prenalterol therapy in severe chronic congestive heart failure.
Topics: Adult; Aged; Cardiac Output, Low; Drug Therapy, Combination; Exercise Test; Female; Heart Failure; H | 1981 |
Continuous hydralazine infusion for afterload reduction.
Topics: Blood Pressure; Cardiac Output; Cardiac Output, Low; Cardiopulmonary Bypass; Female; Hemodynamics; H | 1981 |
Oral hydralazine therapy for acute pulmonary embolism and low output state.
Topics: Administration, Oral; Aged; Cardiac Output, Low; Female; Hemodynamics; Humans; Hydralazine; Pulmonar | 1981 |
Rest and exercise hemodynamic effects of oral hydralazine in patients with coronary artery disease and left ventricular dysfunction.
Topics: Aged; Blood Pressure; Cardiac Output; Cardiac Output, Low; Coronary Disease; Female; Hemodynamics; H | 1980 |
Improving survival for patients with atrial fibrillation and advanced heart failure.
Topics: Adult; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Atrial Fi | 1996 |
Heart failure treatment with angiotensin-converting enzyme inhibitors in hospitalized Medicare patients in 10 large states. The Large State Peer Review Organization Consortium.
Topics: Age Factors; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Cardiac Output, Low; | 1997 |
The AHCPR clinical practice guideline for heart failure revisited.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Calcium Chann | 1997 |
Vasodilator therapy for acute heart failure: haemodynamic comparison of hydralazine/isosorbide, alpha-adrenoceptor blockade, and angiotensin-converting enzyme inhibition.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Cardiac Output, | 1992 |
Significance of coronary circulation in hypertensive heart disease for development and prevention of heart failure.
Topics: Adult; Animals; Cardiac Output, Low; Cardiomegaly; Coronary Circulation; Coronary Disease; Coronary | 1990 |
Treatment of patients with heart failure.
Topics: Arrhythmias, Cardiac; Cardiac Output, Low; Humans; Hydralazine; Isosorbide Dinitrate | 1990 |